Skip to content

FogPharma vs OncoResponse

FogPharma logo

FogPharma

Until everything is druggable

146 employees · est. 2016 · Cambridge, United States

VS
OncoResponse logo

OncoResponse

Interrogating for Cures

10 employees · est. 2016 · Houston, United States

FogPharma is the larger of the two.

Side-by-Side Comparison

FogPharma OncoResponse
Founded
2016 2016
Headquarters
Cambridge, United States Houston, United States
Employees
146 larger 10
Industry
Biopharma, Biotechnology, Health Care Biopharma, Biotechnology, Health Care
Funding Stage
Series E Not tracked yet
Total Funding
$530.27M $117.10M
Funding Rounds
6 6
Services
development of ultra-tunable peptide therapeutics, research and development of novel cancer treatments, platform for drug discovery and innovation Development of novel cancer immunotherapies, Discovery of human antibodies, Partnering with collaborators in immuno-oncology, Preclinical studies
Target Customers
patients with severe diseases, healthcare providers treating cancer and desmoid tumors, research institutions and collaborators in oncology Biopharmaceutical companies, Oncology researchers, Cancer patients, Clinical study collaborators
Taxonomy
Drug DiscoveryHelicon PeptidesPrecision MedicineCell-penetrating PeptidesOncologyCancer Treatment +7 Immuno-oncologyBiotechCancer ImmunotherapyAntibody PlatformB-cell DiscoveryTumor Microenvironment +8
Website
fogpharma.com oncoresponse.com
FogPharma logo

About FogPharma

FogPharma, founded in 2016 and headquartered in the United States, is at the forefront of revolutionizing drug development. Operating within the Biopharma, Biotechnology, Health Care, Life Sciences, and Pharmaceutical industries, their slogan, "Until everything is druggable," encapsulates their ambi...

OncoResponse logo

About OncoResponse

OncoResponse, founded in 2016, is an innovative player in the immuno-oncology biotech sector. This biopharma company is particularly notable for its strategic collaboration with the MD Anderson Cancer Center, which amplifies its capabilities in treating cancer. Utilizing a proprietary B-cell discov...

Also comparing in this category

Comparing more than these two?

Get FogPharma, OncoResponse and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does FogPharma compare?

A PDF of FogPharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

FogPharma was founded in 2016, based in Cambridge, United States, with 146 employees. FogPharma, founded in 2016 and headquartered in the United States, is at the forefront of revolutionizing drug development. Operating within the Biopharma, Biotechnology, Health Care, Life Sciences, a. OncoResponse was founded in 2016, based in Houston, United States, with 10 employees. OncoResponse, founded in 2016, is an innovative player in the immuno-oncology biotech sector. This biopharma company is particularly notable for its strategic collaboration with the MD Anderson Cancer.
FogPharma has raised $530.27M and OncoResponse $117.10M. Latest stage: FogPharma Series E.
Both work in Biopharma, Biotechnology and Health Care and list monoclonal antibodies among their focus areas.

Compare FogPharma with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at FogPharma on 11 Mar 2026, and OncoResponse on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout